Loading...
Ascentage Pharma Group International
ASPHF•PNK
Healthcare
Biotechnology
$5.82
$-0.00(-0.09%)
Ascentage Pharma Group International (ASPHF) AI-Powered Stock Analysis
See how Ascentage Pharma Group International scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerAscentage Pharma Group International (ASPHF) Stock Overall Grade
Ascentage Pharma Group International’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Ascentage Pharma Group International's overall stock rating.
Forecast
C+Score
57/100Financial Growth
A+Score
100/100Fundamental Growth
C+Score
50/100Key Ratios
CScore
42/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Ascentage Pharma Group International (ASPHF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 57/100 (C+), reflecting weak confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (42/100, C) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Ascentage Pharma Group International stock grade, including financials, comparisons, and forecasts.